Table of Contents

2019-2024 Global Biodefense Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biodefense Consumption 2014-2024
2.1.2 Biodefense Consumption CAGR by Region
2.2 Biodefense Segment by Type
2.2.1 Anthrax
2.2.2 Smallpox
2.2.3 Botulism
2.2.4 Radiation/Nuclear
2.2.5 Others
2.3 Biodefense Consumption by Type
2.3.1 Global Biodefense Consumption Market Share by Type (2014-2019)
2.3.2 Global Biodefense Revenue and Market Share by Type (2014-2019)
2.3.3 Global Biodefense Sale Price by Type (2014-2019)
2.4 Biodefense Segment by Application
2.4.1 US Military Market
2.4.2 US Civilian Market
2.4.3 Non - US Market
2.5 Biodefense Consumption by Application
2.5.1 Global Biodefense Consumption Market Share by Application (2014-2019)
2.5.2 Global Biodefense Value and Market Share by Application (2014-2019)
2.5.3 Global Biodefense Sale Price by Application (2014-2019)

3 Global Biodefense by Players
3.1 Global Biodefense Sales Market Share by Players
3.1.1 Global Biodefense Sales by Players (2017-2019)
3.1.2 Global Biodefense Sales Market Share by Players (2017-2019)
3.2 Global Biodefense Revenue Market Share by Players
3.2.1 Global Biodefense Revenue by Players (2017-2019)
3.2.2 Global Biodefense Revenue Market Share by Players (2017-2019)
3.3 Global Biodefense Sale Price by Players
3.4 Global Biodefense Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Biodefense Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Biodefense Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers and Acquisitions, Expansion

4 Biodefense by Regions
4.1 Biodefense by Regions
4.1.1 Global Biodefense Consumption by Regions
4.1.2 Global Biodefense Value by Regions
4.2 Americas Biodefense Consumption Growth
4.3 APAC Biodefense Consumption Growth
4.4 Europe Biodefense Consumption Growth
4.5 Middle East and Africa Biodefense Consumption Growth

5 Americas
5.1 Americas Biodefense Consumption by Countries
5.1.1 Americas Biodefense Consumption by Countries (2014-2019)
5.1.2 Americas Biodefense Value by Countries (2014-2019)
5.2 Americas Biodefense Consumption by Type
5.3 Americas Biodefense Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Biodefense Consumption by Countries
6.1.1 APAC Biodefense Consumption by Countries (2014-2019)
6.1.2 APAC Biodefense Value by Countries (2014-2019)
6.2 APAC Biodefense Consumption by Type
6.3 APAC Biodefense Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Biodefense by Countries
7.1.1 Europe Biodefense Consumption by Countries (2014-2019)
7.1.2 Europe Biodefense Value by Countries (2014-2019)
7.2 Europe Biodefense Consumption by Type
7.3 Europe Biodefense Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East and Africa
8.1 Middle East and Africa Biodefense by Countries
8.1.1 Middle East and Africa Biodefense Consumption by Countries (2014-2019)
8.1.2 Middle East and Africa Biodefense Value by Countries (2014-2019)
8.2 Middle East and Africa Biodefense Consumption by Type
8.3 Middle East and Africa Biodefense Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Biodefense Distributors
10.3 Biodefense Customer

11 Global Biodefense Market Forecast
11.1 Global Biodefense Consumption Forecast (2019-2024)
11.2 Global Biodefense Forecast by Regions
11.2.1 Global Biodefense Forecast by Regions (2019-2024)
11.2.2 Global Biodefense Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East and Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East and Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Biodefense Forecast by Type
11.8 Global Biodefense Forecast by Application

12 Key Players Analysis
12.1 Emergent Biosolutions
12.1.1 Company Details
12.1.2 Biodefense Product Offered
12.1.3 Emergent Biosolutions Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Emergent Biosolutions News
12.2 Hytest
12.2.1 Company Details
12.2.2 Biodefense Product Offered
12.2.3 Hytest Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Hytest News
12.3 GSK
12.3.1 Company Details
12.3.2 Biodefense Product Offered
12.3.3 GSK Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 GSK News
12.4 Sanofi
12.4.1 Company Details
12.4.2 Biodefense Product Offered
12.4.3 Sanofi Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Sanofi News
12.5 PharmAthene
12.5.1 Company Details
12.5.2 Biodefense Product Offered
12.5.3 PharmAthene Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 PharmAthene News
12.6 Bavarian Nordic
12.6.1 Company Details
12.6.2 Biodefense Product Offered
12.6.3 Bavarian Nordic Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Bavarian Nordic News
12.7 SIGA Technologies
12.7.1 Company Details
12.7.2 Biodefense Product Offered
12.7.3 SIGA Technologies Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 SIGA Technologies News
12.8 Arbutus Biopharma
12.8.1 Company Details
12.8.2 Biodefense Product Offered
12.8.3 Arbutus Biopharma Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Arbutus Biopharma News
12.9 DynPort Vaccine
12.9.1 Company Details
12.9.2 Biodefense Product Offered
12.9.3 DynPort Vaccine Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 DynPort Vaccine News
12.10 Xoma Corporation
12.10.1 Company Details
12.10.2 Biodefense Product Offered
12.10.3 Xoma Corporation Biodefense Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Xoma Corporation News
12.11 Ichor Medical Systems
12.12 Aeolus Pharmaceuticals
12.13 Achaogen
12.14 Elusys Therapeutics
12.15 Dynavax Technologies
12.16 Cleveland BioLabs
12.17 Soligenix
12.18 Alnylam Pharmaceuticals

13 Research Findings and Conclusion